Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Botulinum Toxin Type A has become a pivotal agent in modern dermatology, finding applications that range from the correction of dynamic rhytides to adjunctive procedures in surgical settings.

In the clinical evaluations to date, the dose of botulinum toxin type A used to treat gastroparesis ranged from 80 to 200 units. The pyloric sphincter was divided into equal anatomical quadrants, and ...

A second type of Botulinum toxin - type B (brand name Myobloc®) -- may be as effective as type A (brand name Botox®) for the treatment of facial wrinkles, according to UCSF researchers. The study, ...

A Public Health Alerts report today describes the first known US multistate outbreak of infant botulism tied to powdered infant formula, identifying a clear link between illness in dozens of infants ...

Botulinum toxin type A (BTX-A) has emerged as a promising agent in both scar management and wound healing. By inducing temporary muscular paralysis, BTX-A reduces tension across wound edges, thereby ...

For people with idiopathic chronic non-obstructive urinary retention caused by external urethral sphincter dysfunction (also known as Fowler's syndrome in younger women and people with female anatomy, ...

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 to help prevent wrinkles from forming, and I’ve honestly never looked back.

Enterococci are hardy microbes that thrive in the gastrointestinal tracts of nearly all land animals, including our own, and generally cause no harm. But their ruggedness has lately made them leading ...

Currently there's no treatment for botulism once the toxin gets into neurons. This novel treatment neutralized the toxin with a second, modified botulinum toxin that delivered a mini antibody into the ...

In a comprehensive research study, scientists have uncovered a previously unknown mechanism explaining how neurons survive botulinum neurotoxin type A (BoNT/A) exposure, despite the toxin's powerful ...